Glaxo Pays Up

GlaxoSmithKline has agreed to pay $750 million to settle several lawsuits stemming from whistleblower complaints about the company knowingly selling contaminated baby ointment and an ineffective antidepressant, report the New York Times' Gardiner Harris and Duff Wilson. Glaxo sold 20 drugs — including antidepressant Paxil, diabetes drug Avandia, and heart drug Coreg — manufactured at a plant that had contamination problems for many years, Gardiner and Wilson say.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.